IL200482A0 - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive - Google Patents

Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Info

Publication number
IL200482A0
IL200482A0 IL200482A IL20048209A IL200482A0 IL 200482 A0 IL200482 A0 IL 200482A0 IL 200482 A IL200482 A IL 200482A IL 20048209 A IL20048209 A IL 20048209A IL 200482 A0 IL200482 A0 IL 200482A0
Authority
IL
Israel
Prior art keywords
drospirenone
ethinylestradiol
contraceptive
pharmaceutical combination
pharmaceutical
Prior art date
Application number
IL200482A
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL200482(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of IL200482A0 publication Critical patent/IL200482A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL200482A 1999-08-31 2009-08-19 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive IL200482A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (1)

Publication Number Publication Date
IL200482A0 true IL200482A0 (en) 2011-07-31

Family

ID=26153358

Family Applications (2)

Application Number Title Priority Date Filing Date
IL197396A IL197396A (en) 1999-08-31 2009-03-04 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
IL200482A IL200482A0 (en) 1999-08-31 2009-08-19 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL197396A IL197396A (en) 1999-08-31 2009-03-04 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Country Status (11)

Country Link
CN (1) CN1223350C (en)
BG (2) BG109749A (en)
CA (1) CA2382426C (en)
EE (1) EE05317B1 (en)
HR (1) HRP20020258B1 (en)
IL (2) IL197396A (en)
MX (1) MXPA02002043A (en)
NO (3) NO327588B3 (en)
RU (4) RU2269342C9 (en)
SK (1) SK287634B6 (en)
UA (1) UA81387C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (en) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (en) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN108606963B (en) * 2017-12-27 2021-05-18 上海长海医院 Compound contraceptive patch containing drospirenone and estrogen, preparation method and application
CN111529482A (en) * 2020-05-20 2020-08-14 祝培 Testosterone undecanoate sustained-release implant and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (en) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE4344462C2 (en) * 1993-12-22 1996-02-01 Schering Ag Composition for contraception
DE4411585A1 (en) * 1994-03-30 1995-10-05 Schering Ag Combined pharmaceutical preparation for hormonal contraception
WO1998004269A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen

Also Published As

Publication number Publication date
NO2010004I1 (en) 2010-03-22
MXPA02002043A (en) 2003-08-20
NO327588B1 (en) 2009-08-31
EE05317B1 (en) 2010-08-16
RU2010114825A (en) 2011-10-20
EE200900049A (en) 2009-10-15
SK2572002A3 (en) 2002-11-06
BG106533A (en) 2002-10-31
RU2449796C9 (en) 2007-10-27
RU2269342C9 (en) 2007-10-27
BG65204B1 (en) 2007-07-31
RU2269342C2 (en) 2006-02-10
IL197396A (en) 2010-04-29
NO20091809L (en) 2002-04-26
UA81387C2 (en) 2008-01-10
RU2482853C2 (en) 2013-05-27
NO327588B3 (en) 2011-05-16
BG109749A (en) 2008-06-30
CA2382426C (en) 2006-02-28
CN1407895A (en) 2003-04-02
HRP20020258A2 (en) 2005-02-28
RU2005131868A (en) 2007-04-20
SK287634B6 (en) 2011-04-05
RU2449796C2 (en) 2006-02-10
HRP20020258B1 (en) 2007-05-31
NO20083854L (en) 2002-04-26
CA2382426A1 (en) 2001-03-08
RU2396082C2 (en) 2010-08-10
CN1223350C (en) 2005-10-19

Similar Documents

Publication Publication Date Title
HUP0202500A2 (en) Use of a pharmaceutical combination of ethinylestradiol and drospirenone for producing pharmaceutical compositions having contraceptive activity
IL200482A0 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
HUP0200548A2 (en) Pharmaceutical compositions and their use
HUP9900252A3 (en) Hormonal pharmaceutical combined preparation for contraception and kit
ZA200605224B (en) Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
PL340623A1 (en) Oral contraceptive agents containing antistrogen and progestin
ZA9811239B (en) Oral pharmaceutical extended release dosage form
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
HUP0204291A3 (en) Use of composition containing estrogen and drospirenone for hormone replacement therapy
AP9801173A0 (en) Rapidly releasing and taste-making pharmaceutical dosage
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200402458B (en) Estrogen/gestagen combination preparation and application thereof
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
HRP20040584A2 (en) Dosage regimen and pharmaceutical composition for emergency contraception
HK1040055B (en) Use of olanzapine and fluoxetine in the preparation of a medicament for the treatment of treatment resistant major depression
HK1046368A1 (en) Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
IL145188A0 (en) Processes for making pharmaceutical oral ecb formulations and compositions
PL360885A1 (en) 10-aryl-11h-benzo [b]fluorene derivatives and analogs for medicinal use
AP2002002475A0 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
HUP0201478A3 (en) Neuroprotective and retinoprotective ophthalmologic medicines
ZA200201668B (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive.
HUP0900070A3 (en) Use of a pharmaceutical combination of ethinylestradiol and drospirenone as a contraceptive